April 19, 2014 9:42 PM ET

Biotechnology

Company Overview of Inimex Pharmaceuticals Inc.

Company Overview

Inimex Pharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of innate defense regulators (IDRs) that modulate the body's innate defenses without causing inflammation. The company offers IMX942, an IDR product that improves survival, ameliorate tissue damage, and reduce bacterial infections through modulation of innate defenses. Its products are used to treat infections and conditions involving tissue injury; ventilator associated pneumonia, tracheobronchitis, bacteremia, endocarditis, and mucositis; and cancer diseases. Inimex Pharmaceuticals Inc. was founded in 2001 and is headquartered in Coquitlam, Canada.

3650 Wesbrook Mall

RPO Clarke Road

PO Box 64036

Coquitlam, BC V3J 7V6

Canada

Founded in 2001

Phone:

604-225-2251

Fax:

604-225-2257

Key Executives for Inimex Pharmaceuticals Inc.

Chief Executive Officer
Age: 57
Co-Founder and Chairman of Scientific Advisory Board
Chief Financial Officer
Director of Human Resources
Vice President of Corporate Development
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
BELLUS Health (Innodia) Inc. Americas
Alethia BioTherapeutics Inc. Americas
Génétiporc, Inc. Americas
Advanced Therapeutic Technologies At 2 Inc. Americas
QSV Biologics, Ltd. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inimex Pharmaceuticals Inc., please visit www.inimexpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.